NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1396729414 MD
Verify on CMS → Steven Akman, MD
Hematology & Oncology Physician in Charleston, South Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
549
Medicare Part D claims · 111 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Steven Akman, MD filed 549 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Charleston, South Carolina, prescribing 76% generic.
- 549
- Part D claims, 2024
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Steven Akman, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1396729414), first enumerated 12/01/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 549 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1396729414 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1396729414
- ENUM-LEGACY 2005
- TAX-MID 12K Hematology &
- RX-LIGHT 549
- BOOK-THIN 148 in South Carolina
- PHOTO-ENUM Feroze Momin · 2005
Steven Akman, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
549 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Steven Akman, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Steven Akman, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
549 38% vs specialty avg
Specialty distribution in South Carolina
How Hematology & Oncology Physician compares to other specialties among South Carolina providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1396729414 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 12/01/2005 |
Hospital and facility affiliations
Facilities where Steven Akman, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University Medical Associates OF The Medical University OF South Carol
Charleston, SC
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Steven Akman, MD - brand share 24.0%
Hematology & Oncology Physician average
24% brand-name claims vs 76% generic, on 549 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
549
Total Claims
$1.2M
Total Drug Cost
111
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 708.967
- Total Day Supply
- 18,266
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $1.1M
- Generic Drug Cost
- $50K
- Opioid Claims
- 38 (6.9% rate)
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 2.44
- Gender Split
- 73% female / 27% male
- Age Distribution
- <65: 11, 65-74: 47, 75-84: 42, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Steven Akman, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Letrozole
Letrozole
93 claims
- Ondansetron Hcl 27
Ondansetron Hcl
27 claims
- Eliquis 25
Eliquis
25 claims
- Anastrozole 23
Anastrozole
23 claims
- Dexamethasone 17
Dexamethasone
17 claims
- Imatinib Mesylate 14
Imatinib Mesylate
14 claims
- Loperamide 13
Loperamide
13 claims
- Oxycodone Hcl 13
Oxycodone Hcl
13 claims
| Drug | Claims |
|---|---|
| Letrozole | 93 |
| Ondansetron Hcl | 27 |
| Eliquis Apixaban | 25 |
| Anastrozole | 23 |
| Dexamethasone | 17 |
| Imatinib Mesylate | 14 |
| Loperamide Loperamide Hcl | 13 |
| Oxycodone Hcl | 13 |
| Alendronate Sodium | 12 |
| Gabapentin | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology & Oncology Physician in SC →
All providers in South Carolina →
Compare specialties →
Hematology & Oncology Physician Overview
How Steven Akman, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Steven Akman, MD's 549 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Akman, both outside South Carolina so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in South Carolina
Other clinicians with the same primary specialty enrolled in South Carolina, drawn from the same CMS NPPES roster as Akman.
One of 148 Hematology & Oncology Physician providers enrolled in South Carolina, 5 are shown here.
Dr. Mary Ackerman
MD
Columbia, SC
Dr. Samuel Adediran
M.D.,
Spartanburg, SC
Dr. Priyal Agarwal
MD
Charleston, SC
Dr. Jonathan Alexander
M.D.
Charleston, SC
Dr. Faria Ali
MD
Myrtle Beach, SC
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Steven Akman, MD's specialty? ▼
Steven Akman, MD specializes in Hematology & Oncology Physician and practices in Charleston, South Carolina. Credentials: MD.
How much does Steven Akman, MD prescribe under Medicare Part D? ▼
In 2024, Steven Akman, MD wrote 549 Medicare Part D claims totaling $1.2M in drug costs for 111 beneficiaries.
Where is Steven Akman, MD located? ▼
Steven Akman, MD is located at 171 ASHLEY AVE, Charleston, SC, 29425. Phone: (843) 792-1414.
What is Steven Akman, MD's NPI number? ▼
Steven Akman, MD's National Provider Identifier (NPI) is 1396729414, issued on 12/01/2005.
Does Steven Akman, MD prescribe more brand-name or generic drugs? ▼
Steven Akman, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $1.1M in brand drug costs.
Does Steven Akman, MD prescribe opioids? ▼
Yes, Steven Akman, MD had 38 opioid claims in 2024 with an opioid prescribing rate of 6.9%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Steven Akman, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Steven Akman, MD's most frequently prescribed drugs include Letrozole, Ondansetron Hcl, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Steven Akman, MD accept Medicare? ▼
Steven Akman, MD appears in CMS Medicare data with 549 Part D claims and 111 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Steven Akman, MD's credentials? ▼
Steven Akman, MD's NPI is 1396729414 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.